First Time Loading...
S

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990

Watchlist Manager
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Watchlist
Price: 175.7 HKD 1.8% Market Closed
Updated: May 16, 2024
Section:
 

Intrinsic Value

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a CN-based company operating in Biotechnology industry. [ Read More ]

The intrinsic value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock under the Base Case scenario is 92.49 HKD. Compared to the current market price of 175.7 HKD, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is Overvalued by 47%.

Key Points:
Intrinsic Value
Base Case
92.49 HKD
Overvaluation 47%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case
What is intrinsic value?

Valuation Backtest
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

What unique competitive advantages
does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide an overview of the primary business activities
of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

What unique competitive advantages
does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide P/S
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide P/E
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide P/OCF
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide P/FCFE
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide P/B
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide EV/S
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide EV/GP
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide EV/EBITDA
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide EV/EBIT
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide EV/OCF
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide EV/FCFF
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide EV/IC
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Show me price targets
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

What are the Net Income projections
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

What are the EPS projections
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

What are the EBIT projections
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

Compare the revenue forecasts
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Sichuan Kelun-Biotech Biopharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide ROE
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide ROA
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide ROIC
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide ROCE
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Gross Margin
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Operating Margin
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Net Margin
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide FCF Margin
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Show all solvency ratios
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide D/E Ratio
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide D/A Ratio
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Quick Ratio
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Current Ratio
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Provide Cash Ratio
for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

What is the current Free Cash Flow
of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.

Popular Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM
Revenue
Operating Income
Net Income
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Balance Sheet Decomposition
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Balance Sheet Decomposition is not available for
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Efficiency

Earnings Waterfall
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Revenue
803.9m CNY
Cost of Revenue
-276.8m CNY
Gross Profit
527.1m CNY
Operating Expenses
-911.8m CNY
Operating Income
-384.7m CNY
Other Expenses
-231.4m CNY
Net Income
-616.1m CNY
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE

Free Cash Flow Analysis
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Exceptional Revenue Growth Forecast
Negative Operating Income
46/100
Profitability
Score

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Short-Term Solvency
Low Interest Coverage
41/100
Solvency
Score

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Wall Street analysts forecast Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is 184.46 HKD with a low forecast of 109.7 HKD and a high forecast of 220.5 HKD.

Lowest Forecast
Wall Street Target
109.7 HKD
38% Downside
Average Forecast
Wall Street Target
184.46 HKD
5% Upside
Highest Forecast
Wall Street Target
220.5 HKD
25% Upside
Lowest
Price Target
109.7 HKD
38% Downside
Average
Price Target
184.46 HKD
5% Upside
Highest
Price Target
220.5 HKD
25% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

1M 1M
+33%
6M 6M
+95%
1Y 1Y
+181%
3Y 3Y
+181%
5Y 5Y
+181%
10Y 10Y
+181%
Annual Price Range
175.7
52w Low
62.5
52w High
189
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -9%
Shares Statistics
Market Capitalization 37.9B HKD
Shares Outstanding 215 828 600
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Country

China

Industry

Biotechnology

Market Cap

37.9B HKD

Dividend Yield

0%

Description

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Chengdu, Sichuan and currently employs 1,155 full-time employees. The company went IPO on 2023-07-11. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The firm is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The firm's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.

Contact

SICHUAN
Chengdu
No. 666 Xinhua Avenue, Chengdu Cross-Strait Science & Technology Industry Development Park, Wenjiang District
http://www.kelun-biotech.com/

IPO

2023-07-11

Employees

1 155

Officers

President, CEO, COO, GM & Executive Director
Mr. Junyou Ge
CFO & Secretary of the Board
Mr. Zejian Zhou
Executive Director
Dr. Jingyi Wang
Deputy GM, Chief Commercial Officer & Chief Marketing Officer
Mr. Yong Guo
Deputy GM, Chief Strategy Officer & Senior VP
Mr. Yi Feng
Deputy GM and Chief Scientific Officer of Biologics' Research & Development
Dr. Xiangyang Tan
Show More
Deputy GM & Chief Medical Officer
Dr. Xiaoping Jin
Joint Company Secretary
Ms. Wai Sum Fung A.C.I.S., A.C.S.
Show Less

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock?

The intrinsic value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock under the Base Case scenario is 92.49 HKD.

Is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 175.7 HKD, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is Overvalued by 47%.

ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.